Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLIGHT 1: QVA149 in Moderate to Severe COPD
NCT01727141Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2012
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of indacaterol + glycopyrronium in chronic obstructive pulmonary disease (COPD), sponsored by Novartis. Started Nov 2012; status: completed.
02
Drugs
indacaterol + glycopyrronium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01727141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01727141.